Drugmaker Jiang Emerges as Billionaire With Flu Remedies
This article is for subscribers only.
Jiang Wei, the chairman of Guizhou Bailing Group Pharmaceutical Co., has become a billionaire after the Anshun, China-based drugmaker surged 81 percent since June.
Jiang and his mother, Zhang Jinfen, control more than 300 million shares of the Shenzhen Stock Exchange-traded company, according to its annual report. The 64 percent stake is valued at more than $1.2 billion, according to the Bloomberg Billionaires Index.